Pivotpark
Looking for space?
Login
Pivotpark

Aspen Oss and Pivot Park ready to start the  construction of the fit-out of the Panther building

Pivot Park and Aspen Oss have taken another major step forward in the development of the Panther building at Pivot Park. With the construction agreement with Dura Vermeer now officially signed, works on the campus are expected to start on 15 June 2026.

 The project reflects a strong partnership between Aspen Oss, Pivot Park, contractors and consultants, and marks an important next step towards the realisation of a new state-of-the-art facility on the Pivot Park campus. “This project with Aspen Oss marks another important step in the growth of our science park. The Panther building will further strengthen the position of Pivot Park and Oss as a leading hub for life sciences and biopharmaceutical innovation” says Brigitte Drees (CEO Pivot Park).

“The new Panther building will allow Aspen Oss to bring together laboratory activities that are currently spread across several buildings in Oss. It will provide modern facilities for both laboratory and office functions, fully aligned with our ambitions for the future. The building is designed to meet the highest standards for safety, sustainability and energy efficiency, while also strengthening our attractiveness as a partner for customers and for both current and future talent,” says Marcel Broecks, Managing Director of Aspen Oss.

Over the past months, intensive collaboration between Aspen’s future users, the Pivot Project Lead, lab furniture supplier Waldner, Dura Vermeer, CBRE, VKZ B.V. and other contractors and consultants have led to the detailed design of every aspect of the building: the technical design of the fit out of the Panther Building (RZ). All elements have been integrated into an advanced 3D model, currently being finalised and reviewed. Alongside the technical preparations, the contractual and financial agreements have also been completed. The technical design is the basis of the contract with Dura Vermeer.

The building is scheduled for final handover on 2 July 2027, in line with the agreements with Aspen Oss. This milestone marks the official start of the realisation of the Panther building and underlines the shared ambition of Aspen Oss and Pivot Park to invest in a future-ready innovation environment in Oss. 

Panther building Pivot Park
Search

Recent Posts

#100YEARSPHARMAFUTURE

The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.